Market cap
$15.160 M
$2.16 +0.94%
Close of 7 Aug 2026
Revenue
$319.7K
#3573 by revenue
Earnings
-$10.3M
Loss-making
Shares outstanding
7,018,528
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Biotechnology: Pharmaceutical Preparations — ranked by market cap
All 501 →Where these numbers come from
Share counts and financials for Vyome are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.